Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

OTC Monograph User Fees Still On The Table, But Not In Legislation

11 Aug 2017

• By Malcolm Spicer

GoldKeyInPuzzle_1200x675

Related Content

Implementing User Fees Should Be Lighter Lift For FDA This Time Around; Bill Heads To White House

03 Aug 2017

OTC Monograph User Fee Goals Document Beats Authorization To Finish Line

27 Jul 2017

OTC Monograph User Fees Totaling $22m To $34m Floated In Senate Discussion Draft

19 May 2017

Additional Topics

United States Legislation Drug Approval Standards FDA OTC Drugs Consumer

More from Legislation

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.